Medications and Management of Seizures and Mood Stabilization

Overview of Medications Related to Mood Stabilization and Seizure Management

Tegravol

  • Category: Mood stabilizer.
  • Dosage: Requires a super high dose to achieve therapeutic effect.

Falbatol

  • Status: Not discussed in detail but mentioned for relevance to discussions on pancytopenia.

Pancytopenia and Adverse Drug Reactions

  • Pancytopenia is a medical condition characterized by the reduction of red blood cells, white blood cells, and platelets.
  • Adverse reactions to disease-modifying antirheumatic drugs (DMARDs), particularly autoimmune suppressants, can lead to conditions like leukopenia (low white blood cell count).
  • It was noted that 25% of patients experiencing adverse reactions may discontinue their medications.
  • It is essential to monitor patients to prevent them from ceasing medication usage due to side effects.

Common Anti-Seizure Medications

  • Phenytoin (Dilantin):
    • Use: Routine maintenance treatment for seizures.
    • Common Side Effects: Ataxia, nystagmus, and potential heart arrhythmias (bradycardia, heart blocks, Stokes-Adams syndrome).
    • Risks: Caution is advised in patients with heart disease, congestive heart failure, or coronary artery disease.
  • Valproic Acid:
    • Use: Increases GABA (gamma-aminobutyric acid) levels; used for seizure management and migraines.
    • Contraindications: Not recommended for individuals with renal impairment.
  • Levetiracetam (Keppra):
    • Long-term use is common; anecdotal reports suggest low adverse effects.
    • Interactions: May increase effects of other central nervous system (CNS) depressants, including alcohol and benzodiazepines.
  • Gabapentin:
    • Action: Stabilizes brain cell activity and increases GABA levels.
    • Adverse Effects: Can cause weakness (asthenia).

Managing Seizures

  • Status Epilepticus:
    • Defined as a seizure lasting more than five minutes or multiple seizures occurring without recovering in between. Life-threatening complications can arise, leading to potential brain damage and hypoxia.
    • Initial Treatment: Short-acting benzodiazepines (such as Lorazepam or Diazepam) for immediate seizure control, followed by a long-acting drug like phenytoin for maintenance.
    • Typical Clinical Intervention:
      • Monitor vital signs, especially blood pressure and oxygen saturation if feasible.
      • Routine metabolic panels to assess for electrolyte imbalances that may trigger seizures, such as sodium or calcium abnormalities.

Common Causes of Seizures

  • Electrolyte Imbalances:
    • Low/high sodium levels or calcium levels can lead to seizure activity.
  • Patient Demographics:
    • Certain patients may be more predisposed to seizures due to factors like significant stressors, flashing lights, or inadequate nutrition.

Lab Monitoring and Assessments

  • Routine Testing: Regular serum drug levels should be monitored to ensure effective dosing and avoid toxicity.
  • Liver Function Tests:
    • Enzymes to monitor: ALT and AST should remain below 40 IU/L to prevent liver damage.
    • Pancytopenic Indicators: Low platelet count (threshold = 150,000), low white blood cell count (threshold = 5,000), and low red blood cell or hemoglobin counts (normal range for males: 14-18 g/dL, females: 12-16 g/dL).

Key Reminders for Patient Management

  • Encourage adherence to anticonvulsant medication regimens to prevent missed doses.
  • Educate patients about interactions with food and other medications that may exacerbate gastrointestinal distress or other side effects.
  • Advise patients on wearing medical alert bracelets for emergency situations.
  • Alerts regarding adverse reactions particularly associated with phenytoin and valproic acid, emphasizing the importance of routine lab tests to monitor side effects and medication levels.